These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
249 related articles for article (PubMed ID: 2871486)
1. A randomized clinical trial of cyclosporine in cadaveric renal transplantation. Analysis at three years. Canadian Multicentre Transplant Study Group N Engl J Med; 1986 May; 314(19):1219-25. PubMed ID: 2871486 [TBL] [Abstract][Full Text] [Related]
2. Results of the Minnesota randomized prospective trial of cyclosporine versus azathioprine-antilymphocyte globulin for immunosuppression in renal allograft recipients. Sutherland DE; Fryd DS; Strand MH; Canafax DM; Ascher NL; Payne WD; Simmons RL; Najarian JS Am J Kidney Dis; 1985 Jun; 5(6):318-27. PubMed ID: 3893106 [TBL] [Abstract][Full Text] [Related]
3. The effects of delayed function on recipients of cadaver renal allografts. A study of 158 patients randomized to cyclosporine or ALG-azathioprine. Canafax DM; Torres A; Fryd DS; Heil JE; Strand MH; Ascher NL; Payne WD; Sutherland DE; Simmons RL; Najarian JS Transplantation; 1986 Feb; 41(2):177-81. PubMed ID: 3511581 [TBL] [Abstract][Full Text] [Related]
4. A randomized trial comparing cyclosporine with antilymphoblast-globulin-azathioprine for renal allograft recipients. Results at 2 1/2-6 years. Johnson CP; Simmons RL; Sutherland DE; Canafax DM; Ascher NL; Payne WD; Flick B; Najarian JS; Fryd DS Transplantation; 1988 Feb; 45(2):380-5. PubMed ID: 3278431 [TBL] [Abstract][Full Text] [Related]
5. A single institution, randomized, prospective trial of cyclosporin versus azathioprine-antilymphocyte globulin for immunosuppression in renal allograft recipients. Najarian JS; Fryd DS; Strand M; Canafax DM; Ascher NL; Payne WD; Simmons RL; Sutherland DE Ann Surg; 1985 Feb; 201(2):142-57. PubMed ID: 3882063 [TBL] [Abstract][Full Text] [Related]
6. Cyclosporine-steroids versus conventional therapy in cadaver kidney transplantation: analysis of a randomized trial at two years. Gianello P; Squifflet JP; Pirson Y; Stoffel M; Dereme T; Alexandre GP Transplant Proc; 1987 Feb; 19(1 Pt 3):1867-72. PubMed ID: 3547891 [No Abstract] [Full Text] [Related]
7. Beneficial effects of cyclosporine compared with azathioprine in cadaveric renal transplantation. Henry ML; Sommer BG; Ferguson RM Am J Surg; 1985 Nov; 150(5):533-6. PubMed ID: 2998215 [TBL] [Abstract][Full Text] [Related]
8. A randomized clinical trial of cyclosporine in cadaveric renal transplantation. Canadian Multicentre Transplant Study Group N Engl J Med; 1983 Oct; 309(14):809-15. PubMed ID: 6350878 [TBL] [Abstract][Full Text] [Related]
9. Comparison of three immunosuppressive regimens in cadaver renal transplantation: long-term cyclosporine, short-term cyclosporine followed by azathioprine and prednisolone, and azathioprine and prednisolone without cyclosporine. Hall BM; Tiller DJ; Hardie I; Mahony J; Mathew T; Thatcher G; Miach P; Thomson N; Sheil AG N Engl J Med; 1988 Jun; 318(23):1499-507. PubMed ID: 3285215 [TBL] [Abstract][Full Text] [Related]
10. Infectious complications with the use of cyclosporine versus azathioprine after cadaveric kidney transplantation. Shaffer D; Hammer SM; Monaco AP Am J Surg; 1987 Apr; 153(4):381-6. PubMed ID: 3105340 [TBL] [Abstract][Full Text] [Related]
11. Sequential use of Minnesota antilymphoblast globulin and cyclosporine in cadaveric renal transplantation. Kupin WL; Venkatachalam KK; Oh HK; Dienst S; Levin NW Transplantation; 1985 Dec; 40(6):601-4. PubMed ID: 3907029 [TBL] [Abstract][Full Text] [Related]
14. Is sequential low-dose immunotherapy the preferred treatment in cadaveric renal transplantation? Posner MP; Mendez-Picon G; King A; Nelson KP; Spicer HG; Lee HM Transplant Proc; 1989 Feb; 21(1 Pt 2):1594-7. PubMed ID: 2652519 [No Abstract] [Full Text] [Related]
15. Early and late effects of two immunosuppressive drug protocols on recipients of renal allografts: results of the Minnesota randomized trial comparing cyclosporine versus antilymphocyte globulin-azathioprine. Canafax DM; Simmons RL; Sutherland DE; Fryd DS; Strand MH; Ascher NL; Payne WD; Najarian JS Transplant Proc; 1986 Apr; 18(2 Suppl 1):192-6. PubMed ID: 3515687 [No Abstract] [Full Text] [Related]
16. Results of conversion from cyclosporine to azathioprine in cadaveric renal transplantation. Gonwa TA; Nghiem DD; Schulak JA; Corry RJ Transplantation; 1987 Feb; 43(2):225-8. PubMed ID: 3544380 [TBL] [Abstract][Full Text] [Related]
17. Early function as the principal correlate of graft survival. A multivariate analysis of 200 cadaveric renal transplants treated with a protocol incorporating antilymphocyte globulin and cyclosporine. Halloran PF; Aprile MA; Farewell V; Ludwin D; Smith EK; Tsai SY; Bear RA; Cole EH; Fenton SS; Cattran DC Transplantation; 1988 Aug; 46(2):223-8. PubMed ID: 3043779 [TBL] [Abstract][Full Text] [Related]
19. [Acute rejection in cadaveric renal transplantation under cyclosporine based therapy. Analysis of the risk factors and its influence on chronic dysfunction]. Mota A Acta Med Port; 2004; 17(1):8-14. PubMed ID: 15636737 [TBL] [Abstract][Full Text] [Related]
20. Cyclosporine: five years' experience in cadaveric renal transplantation. Merion RM; White DJ; Thiru S; Evans DB; Calne RY N Engl J Med; 1984 Jan; 310(3):148-54. PubMed ID: 6361559 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]